Evolve BioPep
Tirzepatide
Finnrick tested 2 samples of Tirzepatide (GLP-1 and GIP agonist) from Evolve BioPep between 2 Jul 2025 and 18 Sep 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Evolve BioPep
Tirzepatide
Tested 2 Samples
Last test 18 Sep 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Evolve BioPep
Samples are tested in commercial labs
Tests Count
2
Scores
AVGMINMAX
Last
18 Sep 2025
First
2 Jul 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 18 Sep 2025 | View | 30mg | 25.700mg | -14.3% | 99.88% | (no batch ID) | White Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 2 Jul 2025 | View | 30mg | 28.100mg | -6.3% | 98.66% | (no batch ID) | White Label / Silver Crimp / Black Cap | Lab E | Public | |